Dai DN - Search Results

1

Correction to: Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.

Dai DN, Li Y, Chen B, Du Y, Li SB, Lu SX, Zhao ZP, Zhou AJ, Xue N, Xia TL, Zeng MS, Zhong Q, Wei WD. Dai DN, et al. J Mol Med (Berl). 2019 Aug;97(8):1213-1214. doi: 10.1007/s00109-019-01806-9. J Mol Med (Berl). 2019. PMID: 31203376 Free PMC article.

2

Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients.

Dai D, Chen B, Tang H, Wang B, Zhao Z, Xie X, Wei W. Dai D, et al. PLoS One. 2016 Aug 25;11(8):e0161902. doi: 10.1371/journal.pone.0161902. eCollection 2016. PLoS One. 2016. PMID: 27561099 Free PMC article.

3

Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients.

Dai D, Chen B, Wang B, Tang H, Li X, Zhao Z, Li X, Xie X, Wei W. Dai D, et al. J Cancer. 2016 Aug 7;7(12):1747-1754. doi: 10.7150/jca.15776. eCollection 2016. J Cancer. 2016. PMID: 27698913 Free PMC article.

4

Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer.

Chen B, Dai D, Tang H, Ai X, Chen X, Zhang X, Li Z, Xie X. Chen B, et al. PLoS One. 2016 Nov 16;11(11):e0165133. doi: 10.1371/journal.pone.0165133. eCollection 2016. PLoS One. 2016. PMID: 27851755 Free PMC article.

5

Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer.

Chen B, Dai D, Tang H, Chen X, Ai X, Huang X, Wei W, Xie X. Chen B, et al. J Cancer. 2016 Nov 25;7(15):2309-2316. doi: 10.7150/jca.16622. eCollection 2016. J Cancer. 2016. PMID: 27994669 Free PMC article.

6

A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung Cancer.

Zeng Q, Xue N, Dai D, Xing S, He X, Li S, Du Y, Huang C, Li L, Liu W. Zeng Q, et al. J Cancer. 2017 Feb 25;8(5):744-753. doi: 10.7150/jca.17423. eCollection 2017. J Cancer. 2017. PMID: 28382136 Free PMC article.

7

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.

Chen B, Wang J, Dai D, Zhou Q, Guo X, Tian Z, Huang X, Yang L, Tang H, Xie X. Chen B, et al. J Exp Clin Cancer Res. 2017 May 12;36(1):65. doi: 10.1186/s13046-017-0522-4. J Exp Clin Cancer Res. 2017. PMID: 28494797 Free PMC article.

8

Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.

Dai DN, Li Y, Chen B, Du Y, Li SB, Lu SX, Zhao ZP, Zhou AJ, Xue N, Xia TL, Zeng MS, Zhong Q, Wei WD. Dai DN, et al. J Mol Med (Berl). 2017 Aug;95(8):873-886. doi: 10.1007/s00109-017-1537-1. Epub 2017 May 18. J Mol Med (Berl). 2017. PMID: 28523467 Free PMC article.

9

Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis.

Li X, Dai D, Chen B, Tang H, Wei W. Li X, et al. World J Surg Oncol. 2017 Nov 28;15(1):210. doi: 10.1186/s12957-017-1273-6. World J Surg Oncol. 2017. PMID: 29183336 Free PMC article. Review.

10

Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials.

Li X, Dai D, Chen B, Tang H, Xie X, Wei W. Li X, et al. PLoS One. 2018 Feb 6;13(2):e0192464. doi: 10.1371/journal.pone.0192464. eCollection 2018. PLoS One. 2018. PMID: 29408858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters